Association Between ApoA-I (Apolipoprotein A-I) Immune Complexes and Adverse Cardiovascular Events.

CONCLUSIONS: Low levels of ApoA-I/IgG ICs are associated with an increased risk of adverse events in patients with CAD, raising their potential to be used as a biomarker to predict CVD progression.
PMID: 31315438 [PubMed - as supplied by publisher]

Source: Arteriosclerosis, Thrombosis and Vascular Biology - July 17, 2019 Category: Cardiology Authors: Henson D, Tahhan AS, Nardo D, Quyyumi AA, Venditto VJ Tags: Arterioscler Thromb Vasc Biol Source Type: research